Prognostic capacity of preoperative levels of selected blood inflammatory markers for glioma patient’s survival

Thumbnail Image

Date

2018-05

Authors

Yelaman, Konysbek

Journal Title

Journal ISSN

Volume Title

Publisher

Nazarbayev University School of Medicine

Abstract

Glioma is considered to be a rare type of cancer of the central nervous system (CNS) with the average age-adjusted incidence rate of 3.4 per 100, 000 population. Moreover, gliomas are the most common type of malignant brain tumors among adult population. They account for about 80% of all diagnosed brain tumors originating from brain parenchyma. Despite achievements in medical treatment and technologies glioblastoma patients still have poor prognosis with 3-5% of surviving patients after 12-15 months following standard therapy. In addition, recent studies highlight importance of blood, and molecular markers in predicting presence of gliomas.

Description

Keywords

Vascular endothelial growth factor, Isocitrate dehydrogenase, Glioma, central nervous system

Citation

Yelaman, Konysbek. (2018) Prognostic capacity of preoperative levels of selected blood inflammatory markers for glioma patient’s survival. Nazarbayev University School of Medicine

Collections